FR2369292B1 - - Google Patents

Info

Publication number
FR2369292B1
FR2369292B1 FR7702646A FR7702646A FR2369292B1 FR 2369292 B1 FR2369292 B1 FR 2369292B1 FR 7702646 A FR7702646 A FR 7702646A FR 7702646 A FR7702646 A FR 7702646A FR 2369292 B1 FR2369292 B1 FR 2369292B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7702646A
Other languages
French (fr)
Other versions
FR2369292A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to US05/775,215 priority Critical patent/US4153684A/en
Priority to JP2552977A priority patent/JPS52139018A/ja
Priority to DE2710454A priority patent/DE2710454C2/de
Priority to NL7702579A priority patent/NL7702579A/xx
Priority to CH305277A priority patent/CH619469A5/fr
Priority to GB10110/77A priority patent/GB1573126A/en
Priority to DK105477A priority patent/DK151813C/da
Publication of FR2369292A1 publication Critical patent/FR2369292A1/fr
Application granted granted Critical
Publication of FR2369292B1 publication Critical patent/FR2369292B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7702646A 1976-03-10 1977-01-31 Agents adjuvants immunit Granted FR2369292A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US05/775,215 US4153684A (en) 1976-03-10 1977-03-07 Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives
JP2552977A JPS52139018A (en) 1976-03-10 1977-03-10 Immuno adjuvant and antiinfection adjuvant composed of mainly nnacetyll muramiccllalanyllddglutamic ester or nnacetyllmuramiccllalanylldd isoglutamic ester
DE2710454A DE2710454C2 (de) 1976-03-10 1977-03-10 Ester von N-Acetylmuramyl-L-alanyl-D-isoglutamin sowie Mono- und Diester von N-Acetylmuramyl-L-alanyl-D-glutaminsäure, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
NL7702579A NL7702579A (nl) 1976-03-10 1977-03-10 Werkwijze ter bereiding van immuniserende en anti- infectieuze middelen.
CH305277A CH619469A5 (en) 1976-03-10 1977-03-10 Process for the preparation of the esters of N-acetyl-muramyl-L-alanyl-D-glutamic acid and of N-acetyl-muramyl-L-alanyl-D-isoglutamine
GB10110/77A GB1573126A (en) 1976-03-10 1977-03-10 Immunising and anti-infectious adjuvant agents comprising peptide derivatives of muramic acid
DK105477A DK151813C (da) 1976-03-10 1977-03-10 Analogifremgangsmaade til fremstilling af estere af n-acetyl-muramyl-l-alanyl-d-glutaminsyre og af n-acetyl-muramyl-l-alanyl-d-isoglutamin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4559776 1976-11-02

Publications (2)

Publication Number Publication Date
FR2369292A1 FR2369292A1 (fr) 1978-05-26
FR2369292B1 true FR2369292B1 (enExample) 1981-06-26

Family

ID=10437821

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7702646A Granted FR2369292A1 (fr) 1976-03-10 1977-01-31 Agents adjuvants immunit

Country Status (2)

Country Link
US (1) US4272524A (enExample)
FR (1) FR2369292A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4574058A (en) * 1978-02-24 1986-03-04 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
JPS5543030A (en) * 1978-09-21 1980-03-26 Dai Ichi Seiyaku Co Ltd Prophylactic and remedy for microbial infection disease
GR78246B (enExample) * 1981-01-23 1984-09-26 Ciba Geigy Ag
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
FR2533827A1 (fr) * 1982-09-30 1984-04-06 Anvar Composition possedant des proprietes immunoregulatrices, notamment d'adjuvants immunologiques non specifiques, a base de muramylpeptide et d'un derive d'aluminium
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof

Also Published As

Publication number Publication date
FR2369292A1 (fr) 1978-05-26
US4272524A (en) 1981-06-09

Similar Documents

Publication Publication Date Title
JPS5515868B2 (enExample)
JPS555544B2 (enExample)
FR2369292B1 (enExample)
JPS5384840U (enExample)
JPS534425U (enExample)
JPS5512117Y2 (enExample)
JPS5526334Y2 (enExample)
JPS5343888Y2 (enExample)
JPS5620851Y2 (enExample)
JPS5621624Y2 (enExample)
JPS5635480Y2 (enExample)
JPS566014B2 (enExample)
JPS5376677U (enExample)
CS175350B1 (enExample)
DD127366A2 (enExample)
DD126091A1 (enExample)
DD127338A1 (enExample)
DD127216A1 (enExample)
DD125913A1 (enExample)
DD125860A1 (enExample)
DD127167A5 (enExample)
DD127129A1 (enExample)
DD127096A1 (enExample)
BG23437A1 (enExample)
DD126053A1 (enExample)